339 related articles for article (PubMed ID: 19427394)
1. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol.
Makide K; Kitamura H; Sato Y; Okutani M; Aoki J
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):135-9. PubMed ID: 19427394
[TBL] [Abstract][Full Text] [Related]
2. Biological effects of lysophospholipids.
Rivera R; Chun J
Rev Physiol Biochem Pharmacol; 2008; 160():25-46. PubMed ID: 18481029
[TBL] [Abstract][Full Text] [Related]
3. Novel lysophosphoplipid receptors: their structure and function.
Makide K; Uwamizu A; Shinjo Y; Ishiguro J; Okutani M; Inoue A; Aoki J
J Lipid Res; 2014 Oct; 55(10):1986-95. PubMed ID: 24891334
[TBL] [Abstract][Full Text] [Related]
4. Unfolding the pathophysiological role of bioactive lysophospholipids.
Xu Y; Xiao YJ; Zhu K; Baudhuin LM; Lu J; Hong G; Kim KS; Cristina KL; Song L; S Williams F; Elson P; Markman M; Belinson J
Curr Drug Targets Immune Endocr Metabol Disord; 2003 Mar; 3(1):23-32. PubMed ID: 12570723
[TBL] [Abstract][Full Text] [Related]
5. Novel bioactive glycerol-based lysophospholipids: new data -- new insight into their function.
Grzelczyk A; Gendaszewska-Darmach E
Biochimie; 2013 Apr; 95(4):667-79. PubMed ID: 23089136
[TBL] [Abstract][Full Text] [Related]
6. Lysophospholipids as mediators of immunity.
Lin DA; Boyce JA
Adv Immunol; 2006; 89():141-67. PubMed ID: 16682274
[TBL] [Abstract][Full Text] [Related]
7. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
[TBL] [Abstract][Full Text] [Related]
8. Lysophospholipid signaling in the function and pathology of the reproductive system.
Ye X
Hum Reprod Update; 2008; 14(5):519-36. PubMed ID: 18562325
[TBL] [Abstract][Full Text] [Related]
9. Lysophospholipids--receptor revelations.
Hla T; Lee MJ; Ancellin N; Paik JH; Kluk MJ
Science; 2001 Nov; 294(5548):1875-8. PubMed ID: 11729304
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
11. New intercellular lipid mediators and their GPCRs: an update.
Im DS
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):53-6. PubMed ID: 19442546
[TBL] [Abstract][Full Text] [Related]
12. [Elucidation of the functional roles of lysophospholipid mediators and its application in laboratory medicine].
Yatomi Y
Rinsho Byori; 2006 Jul; 54(7):720-31. PubMed ID: 16913663
[TBL] [Abstract][Full Text] [Related]
13. The Many Roles of Lysophospholipid Mediators and Japanese Contributions to This Field.
Takagi Y; Nishikado S; Omi J; Aoki J
Biol Pharm Bull; 2022; 45(8):1008-1021. PubMed ID: 35908884
[TBL] [Abstract][Full Text] [Related]
14. Lysophospholipids and their producing enzymes: Their pathological roles and potential as pathological biomarkers.
Yaginuma S; Omi J; Kano K; Aoki J
Pharmacol Ther; 2023 Jun; 246():108415. PubMed ID: 37061204
[TBL] [Abstract][Full Text] [Related]
15. Identification of GPR55 as a lysophosphatidylinositol receptor.
Oka S; Nakajima K; Yamashita A; Kishimoto S; Sugiura T
Biochem Biophys Res Commun; 2007 Nov; 362(4):928-34. PubMed ID: 17765871
[TBL] [Abstract][Full Text] [Related]
16. Lysophospholipid growth factors and their G protein-coupled receptors in immunity, coronary artery disease, and cancer.
Goetzl EJ; Graeler M; Huang MC; Shankar G
ScientificWorldJournal; 2002 Feb; 2():324-38. PubMed ID: 12806020
[TBL] [Abstract][Full Text] [Related]
17. Lysophospholipids in development: Miles apart and edging in.
Saba JD
J Cell Biochem; 2004 Aug; 92(5):967-92. PubMed ID: 15258919
[TBL] [Abstract][Full Text] [Related]
18. [Progress in the study of physiological function of sphingosine 1-phosphate].
Duan HF; Wang LS; Wu C
Sheng Li Ke Xue Jin Zhan; 2003 Jan; 34(1):16-20. PubMed ID: 12778803
[TBL] [Abstract][Full Text] [Related]
19. [Current studies on a novel lipid mediator, sphingosine 1-phosphate, and its receptors].
Igarashi Y
Tanpakushitsu Kakusan Koso; 2002 Mar; 47(4 Suppl):476-9. PubMed ID: 11915345
[No Abstract] [Full Text] [Related]
20. GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors.
Zhao P; Abood ME
Life Sci; 2013 Mar; 92(8-9):453-7. PubMed ID: 22820167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
